News · 18 November 2026

Judge refuses Novo's bid to stop Lilly's obesity drug ads

18 November 2026 · Business · Health

Judge refuses Novo's bid to stop Lilly's obesity drug ads
Picture: BioPharma Dive · BioPharma Dive lead image · unknown

A federal judge refused on Monday to stop Lilly's ads for its obesity drug Zepbound. Rival Novo, which makes Wegovy, sued Lilly over the ads in July. Novo said they were misleading. The judge ruled that Novo failed to prove the ads hurt its sales. Novo said the ruling is not a final decision on its claims.

Where this came from. 3 outlets reported this. We read them, then wrote the sixty words above.

Also on 18 November 2026